Literature DB >> 8519975

Structural predictions of the binding site architecture for monoclonal antibody NC6.8 using computer-aided molecular modeling, ligand binding, and spectroscopy.

M Viswanathan1, J M Anchin, P R Droupadi, C Mandal, D S Linthicum, S Subramaniam.   

Abstract

Monoclonal antibody NC6.8 binds the superpotent sweetener ligand N-(p-cyanophenyl)-N'-(diphenylmethyl) guanidineacetic acid with high affinity (Kd = 53 nM). Using computer-aided molecular modeling and several experimental techniques, such as competitive ligand binding, absorbance spectroscopy, and fluorescence spectroscopy, we have predicted the structure of the variable domain fragment (Fv) and identified the key residues in the combining site of the antibody. We have identified nine specific amino acids as being involved in ligand recognition and complexation. Most notable are H:33W, which is responsible for ligand-induced tryptophan fluorescence quenching, H:56R, which forms a salt bridge with the carboxylate moiety of the ligand, and L:34H, which, deep in the binding site, interacts with the cyanophenyl portion of the ligand. Two residues located deep in the putative binding pocket, H:35E and H:50E, provide the negatively charged potential for interaction with the protonated aryl nitrogen and the positive guanidinium group. These modeling predictions were made before the solution of high-resolution structures of the native Fab (2.6 A) and the Fab-ligand complex (2.2 A). Comparisons between the theoretical model and experimental native and liganded Fab structures are made.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8519975      PMCID: PMC1236304          DOI: 10.1016/S0006-3495(95)79950-7

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  35 in total

1.  Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-A resolution.

Authors:  T O Fischmann; G A Bentley; T N Bhat; G Boulot; R A Mariuzza; S E Phillips; D Tello; R J Poljak
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

2.  Modeling the antigen combining site of an anti-dinitrophenyl antibody, ANO2.

Authors:  D Bassolino-Klimas; R E Bruccoleri; S Subramaniam
Journal:  Protein Sci       Date:  1992-11       Impact factor: 6.725

Review 3.  Antibody-antigen complexes.

Authors:  D R Davies; E A Padlan; S Sheriff
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

4.  Modeling antibody hypervariable loops: a combined algorithm.

Authors:  A C Martin; J C Cheetham; A R Rees
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  [The primary structure of crystallizable monoclonal immunoglobulin IgG1 Kol. II. Amino acid sequence of the L-chain, gamma-type, subgroup I].

Authors:  H D Kratzin; W Palm; M Stangel; W E Schmidt; J Friedrich; N Hilschmann
Journal:  Biol Chem Hoppe Seyler       Date:  1989-03

6.  Prediction of the folding of short polypeptide segments by uniform conformational sampling.

Authors:  R E Bruccoleri; M Karplus
Journal:  Biopolymers       Date:  1987-01       Impact factor: 2.505

7.  Local and transmitted conformational changes on complexation of an anti-sweetener Fab.

Authors:  L W Guddat; L Shan; J M Anchin; D S Linthicum; A B Edmundson
Journal:  J Mol Biol       Date:  1994-02-11       Impact factor: 5.469

Review 8.  Structural basis of antibody function.

Authors:  D R Davies; H Metzger
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

9.  Three-dimensional structure of a fluorescein-Fab complex crystallized in 2-methyl-2,4-pentanediol.

Authors:  J N Herron; X M He; M L Mason; E W Voss; A B Edmundson
Journal:  Proteins       Date:  1989

10.  Three-dimensional structure of two crystal forms of FabR19.9 from a monoclonal anti-arsonate antibody.

Authors:  M B Lascombe; P M Alzari; R J Poljak; A Nisonoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

View more
  1 in total

1.  Structural models of antibody variable fragments: a method for investigating binding mechanisms.

Authors:  S Petit; F Brard; G Coquerel; G Perez; F Tron
Journal:  J Comput Aided Mol Des       Date:  1998-03       Impact factor: 3.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.